PREVACID 24HR OTC
Generic Name and Formulations:
Lansoprazole 15mg; e-c delayed-release granules in caps.
Novartis Consumer Health
Indications for PREVACID 24HR:
Frequent heartburn (≥2 days/week). Not intended for immediate relief of heartburn (may take 1–4 days for full effect).
Swallow whole. Take before eating in the AM. ≥18yrs: 15mg once daily for 14 days; may repeat 14-day course every 4 months.
<18yrs: not recommended.
Liver disease. Heartburn >3 months. Chest or shoulder pain. Frequent wheezing. Unexplained weight loss. Nausea/vomiting. Stomach pain. Reevaluate if condition continues or worsens after 14 days. Require >1 course of treatment every 4 months. Pregnancy. Nursing mothers.
Proton pump inhibitor.
May affect or be affected by blood-thinning agents (eg, warfarin), antifungals, digoxin, theophylline, tacrolimus, mycophenolate mofetil, atazanavir, methotrexate.
Diarrhea, rash, joint pain; discontinue if occur.
Caps—14, 28, 42
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Comorbid Narcolepsy and Schizophrenia in Adolescents
- Ketamine in Electroconvulsive Therapy Accelerates Antidepressive Effects
- Quetiapine Exposure Does Not Appear to Increase Risk for Infant Malformations
- Selective Serotonin Reuptake Inhibitors May Increase Risk for Suboptimal Fetal Growth
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Prenatal Insecticide Exposure in Mother May Be Linked to Risk for Autism in Children